Clinical Trial Update: Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating oxaliplatin, capecitabine, and radiation therapy in locally advanced rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED